{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:01Z","timestamp":1761630481289},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.lungcan.2007.11.009","type":"journal-article","created":{"date-parts":[[2008,4,18]],"date-time":"2008-04-18T16:20:30Z","timestamp":1208535630000},"page":"61-66","source":"Crossref","is-referenced-by-count":8,"title":["Phase II trial of gemcitabine\/carboplatin followed by paclitaxel in patients with performance status=2,3 or other significant co-morbidity (HIV infection or s\/p organ transplantation) in advanced non-small cell lung cancer"],"prefix":"10.1016","volume":"61","author":[{"given":"Benjamin B.","family":"Bridges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leno","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr F.","family":"Hausner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Austin","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Bedor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Brahmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April (4)","key":"10.1016\/j.lungcan.2007.11.009_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1200\/JCO.1988.6.4.633","article-title":"Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer\u2014report of a Canadian multicenter randomized trial","volume":"6","author":"Rapp","year":"1988","journal-title":"J Clin Oncol"},{"issue":"January (10)","key":"10.1016\/j.lungcan.2007.11.009_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"issue":"December (24)","key":"10.1016\/j.lungcan.2007.11.009_bib3","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"issue":"November (10)","key":"10.1016\/j.lungcan.2007.11.009_bib4","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/1097-0142(20011115)92:10<2639::AID-CNCR1617>3.0.CO;2-8","article-title":"Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma","volume":"92","author":"Sweeney","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2007.11.009_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.2005.07.172","article-title":"Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730)","volume":"23","author":"Lilenbaum","year":"2005","journal-title":"J Clin Oncol"},{"issue":"February (4)","key":"10.1016\/j.lungcan.2007.11.009_bib6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1200\/JCO.2005.04.9452","article-title":"Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599","volume":"25","author":"Langer","year":"2007","journal-title":"J Clin Oncol"},{"issue":"March (9)","key":"10.1016\/j.lungcan.2007.11.009_bib7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2005.03.4413","article-title":"Elevated incidence of lung cancer among HIV-infected individuals","volume":"24","author":"Engels","year":"2006","journal-title":"J Clin Oncol"},{"issue":"January (1)","key":"10.1016\/j.lungcan.2007.11.009_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11864-006-0034-5","article-title":"Bronchogenic carcinoma in solid organ transplant recipients","volume":"7","author":"Bellil","year":"2006","journal-title":"Curr Treat Options Oncol"},{"issue":"September (6)","key":"10.1016\/j.lungcan.2007.11.009_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.TP.0000173775.16579.18","article-title":"Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales","volume":"80","author":"Oo","year":"2005","journal-title":"Transplantation"},{"issue":"April (4)","key":"10.1016\/j.lungcan.2007.11.009_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.JTO.0000263707.31202.d7","article-title":"Lung cancer in HIV infected patients in the era of highly active antiretroviral therapy","volume":"2","author":"Hakimian","year":"2007","journal-title":"J Thorac Oncol"},{"issue":"February (3)","key":"10.1016\/j.lungcan.2007.11.009_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D","article-title":"Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors","volume":"88","author":"Tirelli","year":"2000","journal-title":"Cancer"},{"issue":"July (1)","key":"10.1016\/j.lungcan.2007.11.009_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1097-0142(20010701)92:1<146::AID-CNCR1302>3.0.CO;2-N","article-title":"Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel","volume":"92","author":"Edelman","year":"2001","journal-title":"Cancer"},{"issue":"September (Suppl 1)","key":"10.1016\/j.lungcan.2007.11.009_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0169-5002(00)80049-5","article-title":"Sequential chemotherapy with carboplatin and gemcitabine followed by placlitaxel in poor performance status and elderly patients with non-small cell lung cancer","volume":"29","author":"Edelman","year":"2000","journal-title":"Lung Cancer"},{"issue":"May (10)","key":"10.1016\/j.lungcan.2007.11.009_bib14","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/cncr.11375","article-title":"Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B","volume":"97","author":"Akerley","year":"2003","journal-title":"Cancer"},{"issue":"July (2)","key":"10.1016\/j.lungcan.2007.11.009_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"issue":"August (15)","key":"10.1016\/j.lungcan.2007.11.009_bib16","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1158\/1078-0432.CCR-04-0002","article-title":"Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin\/gemcitabine followed by paclitaxel or cisplatin\/vinorelbine followed by docetaxel","volume":"10","author":"Edelman","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"June (Suppl)","key":"10.1016\/j.lungcan.2007.11.009_bib17","article-title":"Phase III study of immediate versus delayed docetaxel after induction therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer: Updates report with survival","author":"Fidias","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.lungcan.2007.11.009_bib18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/01243894-200607000-00007","article-title":"Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and\/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027)","volume":"1","author":"Hesketh","year":"2006","journal-title":"J Thorac Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500207006770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500207006770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:10:54Z","timestamp":1557483054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500207006770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0169500207006770"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2007.11.009","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}